Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. drug screening in drug resistant
Show results for
Articles

Refine by
Date

  • This Year
  • Older

Drug Screening In Drug Resistant Articles & Analysis

55 articles found

Understanding the BCL2 Gene Family: Function, Research Highlights, and Medical Relevance

Understanding the BCL2 Gene Family: Function, Research Highlights, and Medical Relevance

The BCL2 gene, short for B-cell lymphoma 2, is a critical regulator of apoptosis, or programmed cell death. It belongs to a larger BCL2 gene family, which includes both pro-apoptotic and anti-apoptotic proteins that maintain a delicate balance between cell survival and cell death. Dysregulation of this gene family is implicated in a variety of diseases, most notably cancer. What is BCL2? The ...

ByCreative BioMart


Drug Screening in Drug-Resistant Cells: A Critical Approach to Overcoming Treatment Challenges

Drug Screening in Drug-Resistant Cells: A Critical Approach to Overcoming Treatment Challenges

The effectiveness of current therapies is often hindered by the ability of certain cell populations to develop resistance, leading to treatment failure and disease progression. This article explores the importance of drug screening in drug-resistant cells and its implications for advancing therapeutic strategies. ...

ByCreative Biogene


Custom Knockout Cell Lines: Revolutionizing Research and Therapeutics

Custom Knockout Cell Lines: Revolutionizing Research and Therapeutics

By creating cell lines with specific genes “knocked out,” scientists can investigate disease mechanisms, screen drug candidates, and develop gene therapies more effectively. This article explores the significance, methodologies, applications, and future prospects of custom knockout cell lines. ...

ByCreative Bioarray


Understanding Colorectal Cancer Cell Lines: A Vital Tool in Cancer Research

Understanding Colorectal Cancer Cell Lines: A Vital Tool in Cancer Research

These cell lines serve as essential models for studying the biology of colorectal cancer, testing new therapies, and exploring the mechanisms of drug resistance. What are Colorectal Cancer Cell Lines? Colorectal cancer cell lines are cultured cells derived from tumor tissues of patients diagnosed with colorectal cancer. ...

ByCreative Bioarray


Lysozyme Leading the Way in Biotechnology and Health   

Lysozyme Leading the Way in Biotechnology and Health  

Lysozyme, also known as muramidase or N-acetylmuramide glycanhydrolase, is an essential enzyme found widely in nature and recognized for its potent antimicrobial properties. First discovered by Alexander Fleming in 1922, lysozyme has been a subject of considerable scientific and commercial interest owing to its role as an effective biological defense mechanism. Commonly found in egg whites, human ...

ByCreative Enzymes


Alfa Cytology Introduces Comprehensive Small Molecule PARPi Development Services for Combating Various Diseases

Alfa Cytology Introduces Comprehensive Small Molecule PARPi Development Services for Combating Various Diseases

Alfa Cytology introduces comprehensive small molecule PARPi development services for combating various diseases. Alfa Cytology, a developer of oncology innovation, has announced its latest venture small molecule Poly(ADP-ribose) polymerase inhibitor development services. This cutting-edge initiative represents a major advancement in creating more precise and versatile cancer treatment ...

ByAlfa Cytology


PROTAC Technology: Modular Construction of Drug Molecules

PROTAC Technology: Modular Construction of Drug Molecules

What Is PROTAC Technology? Proteolytic targeting chimera (PROTAC) is a new type of drug design technology that works by inducing the degradation of target proteins. Unlike conventional small molecules that typically inhibit protein function, PROTACs facilitate the ubiquitination and subsequent degradation of specific proteins. This bifunctional molecule consists of two distinct elements: a ...

ByAlfa Chemistry


Advancements in Sequencing Technologies: Transforming Pathogen Detection and Clinical Diagnostic   

Advancements in Sequencing Technologies: Transforming Pathogen Detection and Clinical Diagnostic  

In recent years, the landscape of sequencing technologies has undergone a transformative shift, transitioning from research settings to the realm of clinical laboratories. This transformation has been catalyzed by rapid technological advancements and significant cost reductions. Despite a multitude of microorganisms known to inflict human infections, prevailing diagnostic techniques merely ...

ByCD Genomics


Clonality Analysis Service: A Paradigm Shift in Disease Diagnosis and Treatment

Clonality Analysis Service: A Paradigm Shift in Disease Diagnosis and Treatment

Understanding Clonality Analysis Clonality refers to the origin of a cell population from a single 'parent' or progenitor cell through asexual reproduction or division. This concept is vital in cancer studies as it helps track the development of tumor cells from a single mutated cell. Clonality analysis is thus essential in understanding the evolution and the spread of cancerous cells in a ...

ByCreative Bioarray


Drug Conjugates: Latest Research Progress

Drug Conjugates: Latest Research Progress

With the approval of many antibody-drug conjugation (ADC) drugs around the world since 2019, conjugate drugs have developed into one of the hottest tracks in the pharmaceutical industry. Not only the research and development of traditional ADCs continues to be hot, but various new drug conjugates (NDCs) are also blooming. In this article, we make statistics on the research and development ...

ByBOC Sciences


Antibody-Drug Conjugates: New Strategies of ADC Payloads

Antibody-Drug Conjugates: New Strategies of ADC Payloads

The concept of ADCs was first proposed by Nobel Prize winner Paul Ehrlich in 1913. But it was not until 1975, when hybridoma technology began to be used to produce monoclonal antibodies, that the era of ADC drug development truly began. Driven by increasingly mature technology, ADC drugs have gone through three iterations (Fig. 1). Although ADCs have gone through three iterations, current ...

ByBOC Sciences


Clonality Analysis Service: A Paradigm Shift in Disease Diagnosis and Treatment

Clonality Analysis Service: A Paradigm Shift in Disease Diagnosis and Treatment

Understanding Clonality Analysis Clonality refers to the origin of a cell population from a single 'parent' or progenitor cell through asexual reproduction or division. This concept is vital in cancer studies as it helps track the development of tumor cells from a single mutated cell. Clonality analysis is thus essential in understanding the evolution and the spread of cancerous cells in a ...

ByCreative Bioarray


Bispecific Antibodies and Bispecific Antibody ADCs

Bispecific Antibodies and Bispecific Antibody ADCs

With the rapid development of antibody-drug conjugate (ADC), more and more companies have entered the field of ADC research and development, and various types of ADC technologies and branches have emerged. Bispecific antibody conjugates (BsAb ADCs) are one of the emerging new technologies. The high specificity of bispecific antibodies enables more precise targeting of tumor cells. On the other ...

ByBOC Sciences


Mechanisms to Combat Drug Resistance: Overview of Antimicrobial Peptides

Mechanisms to Combat Drug Resistance: Overview of Antimicrobial Peptides

What are Antimicrobial Peptides? Antimicrobial peptides (AMPs) are naturally occurring peptide molecules found in various organisms, including humans, animals, plants, and microorganisms. These peptides play a crucial role in the innate immune system's defense against microbial infections, exhibiting antimicrobial properties that can inhibit the growth or kill bacteria, fungi, viruses, and even ...

ByBOC Sciences


Peptide Vaccine Design

Peptide Vaccine Design

Vaccines are considered one of the most successful medical interventions in the past few centuries, aiming to harness the human immune system and generate lasting protection against specific diseases. Traditional vaccines rely on the use of inactivated pathogens to trigger an immune response. However, many of these formulations carry a high risk of causing allergies or autoimmune reactions. ...

ByCreative Peptides


Based on Antibody Targeted Protein Degradation

Based on Antibody Targeted Protein Degradation

In recent years, PROteolysis TArgeting Chimeras (PROTAC), which utilizes the cell's own degradation mechanisms to eliminate specific disease-related proteins, has emerged as one of the most promising methods. Apart from PROTAC, various targeted protein degradation (TPD) strategies are emerging, involving molecular glue, Autophagy-Targeting Chimera (AUTEC), Autophagosome Tethering Compound ...

ByBOC Sciences


Application of Whole Plasmid Sequencing in Analyzing Drug Resistance Genes of Klebsiella pneumoniae

Application of Whole Plasmid Sequencing in Analyzing Drug Resistance Genes of Klebsiella pneumoniae

Importance of Validating Drug Resistance Genes While drug resistance genes identified through plasmid sequencing may show resistance in heterologous hosts, it is imperative to ascertain their resistance in their natural reservoirs. Additionally, drug-resistant ...

ByCD Genomics


Hiden HPR-60 MBMS Analysis for Low Temperature Plasma (LTP) in Biomedical Engineering

Hiden HPR-60 MBMS Analysis for Low Temperature Plasma (LTP) in Biomedical Engineering

ByHiden Analytical Ltd.


ADC Drugs For HER2 Positive Breast Cancer

ADC Drugs For HER2 Positive Breast Cancer

According to the latest data, breast cancer has overtaken lung cancer to become the most common cancer among women, and the death rate is the second highest among female tumors, seriously affecting the physical and mental health of women around the world. Patients with abnormal expression of human epidermal growth factor receptor (HER2) account for 15%-20% of all breast cancers, which is highly ...

ByHunan Huateng Pharmaceutical Co. Ltd.


Development Trends And Potential Challenges of PROTACs

Development Trends And Potential Challenges of PROTACs

PROTAC technology has been in development for more than 20 years. PROTAC proof-of-concept studies date back to 2001, when Crews' team tested the possibility of artificially induced intracellular protein degradation with a peptide that was too large in molecular weight and required cells to penetrate the peptide to improve cell permeability. The discovery of the first small molecule PROTAC and the ...

ByBiopharma PEG Scientific Inc

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT